Abstract
Bioluminescence-based analytical tools are suitable for high-throughput and high-content screening assays, finding widespread application in several fields related to the drug discovery process. Cell-based bioluminescence assays, because of their peculiar advantages of predictability, possibility of automation, multiplexing, and miniaturization, seem the most appealing tool for the high demands of the early stages of drug screening. Reporter gene technology and the bioluminescence resonance energy transfer principle are widely used, and receptor binding studies of new agonists/antagonists for a variety of human receptors expressed in different cell lines can be performed. Moreover, bioluminescence can be used for in vitro and in vivo real-time monitoring of pathophysiological processes within living cells and small animals. New luciferases and substrates have recently arrived on the market, further expanding the spectrum of applications. A new generation of probes are also emerging that promise to revolutionize the preclinical imaging market. This formidable toolbox is demonstrated to facilitate the implementation of the three Rs principle in the early drug discovery process, in compliance with ethical and responsible research to reduce cost and improve the reliability and predictability of results.
Similar content being viewed by others
References
Timmins GS, Jackson SK, Swartz HM (2001) The evolution of bioluminescent oxygen consumption as an ancient oxygen detoxification mechanism. J Mol Evol 52:321–332
Ow DW, DE Wet JR, Helinski DR, Howell SH, Wood KV, Deluca M (1986) Transient and stable expression of the firefly luciferase gene in plant cells and transgenic plants. Science 234:856–859
Russell WMS, Burch RL (1959) The principles of humane experimental technique. Methuen, London
Schechtman LM (2002) Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods. ILAR J 43:S85–S94
Michelini E, Cevenini L, Calabretta MM, Spinozzi S, Camborata C, Roda A (2013) Field-deployable whole-cell bioluminescent biosensors: so near and yet so far. Anal Bioanal Chem 405:6155–6163
Ando Y, Niwa K, Yamada N, Enomot T, Irie T, Kubota H, Ohmiya Y, Akiyama H (2008) Firefly bioluminescence quantum yield and colour change by pH-sensitive green emission. Nat Photonics 2:44–47
Leclerc GM, Boockfor FR, Faught WJ, Frawley LS (2000) Development of a destabilized firefly luciferase enzyme for measurement of gene expression. Biotechniques 29:590–591
Woo J, Howell MH, von Arnim AG (2008) Structure-function studies on the active site of the coelenterazine-dependent luciferase from Renilla. Protein Sci 17:725–735
Nakatsu T, Ichiyama S, Hiratake J, Saldanha A, Kobashi N, Sakata K, Kato H (2006) Structural basis for the spectral difference in luciferase bioluminescence. Nature 440:372–376
Navizet I, Liu YJ, Ferré N, Roca-Sanjuán D, Lindh R (2011) The chemistry of bioluminescence: an analysis of chemical functionalities. ChemPhysChem 12:3064–3076
Vieira J, Pinto da Silva L, Esteves da Silva JC (2012) Advances in the knowledge of light emission by firefly luciferin and oxyluciferin. J Photochem Photobiol B 117:33–39
Branchini BR, Ablamsky DM, Davis AL, Southworth TL, Butler B, Fan F, Jathoul AP, Pule MA (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal Biochem 396:290–297
Roda A, Mezzanotte L, Aldini R, Michelini E, Cevenini L (2010) A new gastric-emptying mouse model based on in vivo non-invasive bioluminescence imaging. Neurogastroenterol Motil 22:1117–e288
Michelini E, Donati M, Aldini R, Cevenini L, Mezzanotte L, Nardini P, Foschi C, Zvi IB, Cevenini M, Montagnani M, Marangoni A, Roda A, Cevenini R (2012) Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. Anal Biochem 430:92–96
Didiot MC, Serafini S, Pfeifer MJ, King FJ, Parker CN (2011) Multiplexed reporter gene assays: monitoring the cell viability and the compound kinetics on luciferase activity. J Biomol Screen 16:786–793
Hosseinkhani S (2011) Molecular enigma of multicolor bioluminescence of firefly luciferase. Cell Mol Life Sci 68:1167–1182
da Silva LP, da Silva JC (2011) Study on the effects of intermolecular interactions on firefly multicolor bioluminescence. ChemPhysChem 12:3002–3008
Wang Y, Akiyama H, Terakado K, Nakatsu T (2013) Impact of site-directed mutant luciferase on quantitative green and orange/red emission intensities in firefly bioluminescence. Sci Rep 3:2490
Alam R, Fontaine DM, Branchini BR, Maye MM (2012) Designing quantum rods for optimized energy transfer with firefly luciferase enzymes. Nano Lett 12:3251–3256
Xiong L, Shuhendler AJ, Rao J (2012) Self-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imaging. Nat Commun 3:1193
Conley NR, Dragulescu-Andrasi A, Rao J, Moerner WE (2012) A selenium analogue of firefly D-luciferin with red-shifted bioluminescence emission. Angew Chem Int Ed 51:3350–3353
Viviani VR, Arnoldi FG, Venkatesh B, Neto AJ, Ogawa FG, Oehlmeyer AT, Ohmiya Y (2006) Active-site properties of Phrixotrix railroad worm green and red bioluminescence-eliciting luciferases. J Biochem 140:467–474
Rowe L, Combs K, Deo S, Ensor C, Daunert S, Qu X (2008) Genetically modified semisynthetic bioluminescent photoprotein variants: simultaneous dual-analyte assay in a single well employing time resolution of decay kinetics. Anal Chem 80:8470–8476
Natashin PV, Markova SV, Lee J, Vysotski ES, Liu ZJ (2014) Crystal structures of the F88Y obelin mutant before and after bioluminescence provide molecular insight into spectral tuning among hydromedusan photoproteins. FEBS J 281:1432–1445
Cali JJ, Niles A, Valley MP, O’Brien MA, Riss TL, Shultz J (2008) Bioluminescent assays for ADMET. Expert Opin Drug Metab Toxicol 4:103–120
Michelini E, Cevenini L, Mezzanotte L, Coppa A, Roda A (2010) Cell-based assays: fuelling drug discovery. Anal Bioanal Chem 398:227–238
Thorne N, Shen M, Lea WA, Simeonov A, Lovell S, Auld DS, Inglese J (2012) Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter. Chem Biol 19:1060–1072
Ho PI, Yue K, Pandey P, Breault L, Harbinski F, McBride AJ, Webb B, Narahari J, Karassina N, Wood KV, Hill A, Auld DS (2013) Reporter enzyme inhibitor study to aid assembly of orthogonal reporter gene assays. ACS Chem Biol 8:1009–1017
Cheng KC, Inglese J (2012) A coincidence reporter-gene system for high-throughput screening. Nat Methods 9:937
Nakamura K, Mizutani R, Sanbe A, Enosawa S, Kasahara M, Nakagawa A, Ejiri Y, Murayama N, Miyamoto Y, Torii T, Kusakawa S, Yamauchi J, Fukuda M, Yamazaki H, Tanoue A (2011) Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system. J Biosci Bioeng 111:78–84
Ramaiahgari SC, den Braver MW, Herpers B, Terpstra V, Commandeur JN, van de Water B, Price LS. Arch Toxicol (2014) A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch Toxicol 88:1083–1095
Bellis AD, Bernabé BP, Weiss MS, Shin S, Weng S, Broadbelt LJ, Shea LD (2013) Dynamic transcription factor activity profiling in 2D and 3D cell cultures. Biotechnol Bioeng 110:563–572
Weiss MS, Peñalver Bernabé B, Bellis AD, Broadbelt LJ, Jeruss JS, Shea LD (2010) Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture. PLoS One 5:e14026
Paguio A, Stecha P, Wood KV, Fan F (2010) Improved dual-luciferase reporter assays for nuclear receptors. Curr Chem Genomics 4:43–49
Sedlák D, Paguio A, Bartůněk P (2011) Two panels of steroid receptor luciferase reporter cell lines for compound profiling. Comb Chem High Throughput Screen 14:248–266
Cevenini L, Michelini E, D’Elia M, Guardigli M, Roda A (2013) Dual-color bioluminescent bioreporter for forensic analysis: evidence of androgenic and anti-androgenic activity of illicit drugs. Anal Bioanal Chem 405:1035–1045
Caland F, Miron S, Brie D, Mustin C (2011) A Candecomp/Parafac approach to the estimation of environmental pollutant concentrations using biosensors. In: 2011 I.E. statistical signal processing workshop (SSP), pp 801-804
Heise K, Oppermann H, Meixensberger J, Gebhardt R, Gaunitz F (2013) Dual luciferase assay for secreted luciferases based on Gaussia and NanoLuc. Assay Drug Dev Technol 11:244–252
Michelini E, Cevenini L, Mezzanotte L, Ablamsky D, Southworth T, Branchini BR, Roda A (2008) Combining intracellular and secreted bioluminescent reporter proteins for multicolor cell-based assays. Photochem Photobiol Sci 7:212–217
Paulmurugan R, Gambhir SS (2005) Novel fusion protein approach for efficient high-throughput screening of small molecule-mediating protein-protein interactions in cells and living animals. Cancer Res 6516:7413–7420
Dothager RS, Flentie K, Moss B, Pan MH, Kesarwala A, Piwnica-Worms D (2009) Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol 20:45–53
Chung E, Yamashita H, Au P, Tannous BA, Fukumura D, Jain RK (2009) Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS One 4:e8316
Godinat A, Park HM, Miller SC, Cheng K, Hanahan D, Sanman LE, Bogyo M, Yu A, Nikitin GF, Stahl A, Dubikovskaya EA (2013) A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice. ACS Chem Biol 8:987–999
Dressler H, Economides K, Favara S, Wu NN, Pang Z, Polites HG (2014) The CRE luc bioluminescence transgenic mouse model for detecting ligand activation of GPCRs. J Biomol Screen 19:232–241
Pei Z, Lan X, Cheng Z, Qin C, Xia X, Yuan H, Ding Z, Zhang Y (2014) Multimodality molecular imaging to monitor transplanted stem cells for the treatment of ischemic heart disease. PLoS One 9:e90543
Behrooz A, Kuo C, Xu H, Rice B (2013) Adaptive row-action inverse solver for fast noise-robust three-dimensional reconstructions in bioluminescence tomography: theory and dual-modality optical/computed tomography in vivo studies. J Biomed Opt 18:76010
Weissleder R, Ntziachristos V (2003) Shedding light onto live molecular targets. Nat Med 9:123–128
Hasegawa M, Tsukasaki Y, Ohyanagi T, Jin T (2013) Bioluminescence resonance energy transfer coupled near-infrared quantum dots using GST-tagged luciferase for in vivo imaging. Chem Commun 49:228–230
Kuzyniak W, Adegoke O, Sekhosana K, D’Souza S, Tshangana SC, Hoffmann B, Ermilov EA, Nyokong T, Höpfner M (2014) Synthesis and characterization of quantum dots designed for biomedical use. Int J Pharm 466:382–389
Dragulescu-Andrasi A, Chan CT, De A, Massoud TF, Gambhir SS (2011) Bioluminescence resonance energy transfer (BRET) imaging of protein-protein interactions within deep tissues of living subjects. Proc Natl Acad Sci U S A 108:12060–12065
Luker KE, Mihalko LA, Schmidt BT, Lewin SA, Ray P, Shcherbo D, Chudakov DM, Luker GD (2011) In vivo imaging of ligand receptor binding with Gaussia luciferase complementation. Nat Med 18:172–177
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the topical collection Analytical Bioluminescence and Chemiluminescence with guest editors Elisa Michelini and Mara Mirasoli.
Rights and permissions
About this article
Cite this article
Michelini, E., Cevenini, L., Calabretta, M.M. et al. Exploiting in vitro and in vivo bioluminescence for the implementation of the three Rs principle (replacement, reduction, and refinement) in drug discovery. Anal Bioanal Chem 406, 5531–5539 (2014). https://doi.org/10.1007/s00216-014-7925-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-014-7925-2